Mark Hansen

2.0k total citations
23 papers, 1.4k citations indexed

About

Mark Hansen is a scholar working on Molecular Biology, Infectious Diseases and Surgery. According to data from OpenAlex, Mark Hansen has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Mark Hansen's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Heart Failure Treatment and Management (3 papers). Mark Hansen is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Heart Failure Treatment and Management (3 papers). Mark Hansen collaborates with scholars based in United States, Norway and Belgium. Mark Hansen's co-authors include Frederic D. Bushman, Denise Rhodes, Gabrielle Kardon, Kathleen Rubins, D. John Faulkner, M. Rama Rao, M. Venkata Rami Reddy, Y. Venkateswarlu, Jonathan A. Epstein and David A. Hutcheson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Mark Hansen

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Hansen United States 14 667 295 221 191 161 23 1.4k
Markus A. Riederer Switzerland 19 1.0k 1.5× 92 0.3× 278 1.3× 315 1.6× 32 0.2× 34 3.0k
Alan H. Davidson United Kingdom 17 588 0.9× 334 1.1× 35 0.2× 77 0.4× 67 0.4× 43 1.7k
Vitaly A. Polunovsky United States 25 1.7k 2.6× 81 0.3× 89 0.4× 181 0.9× 91 0.6× 41 2.4k
Hsiang Fu Kung Hong Kong 28 900 1.3× 83 0.3× 47 0.2× 109 0.6× 59 0.4× 39 1.7k
Richard Kowalski United States 14 503 0.8× 314 1.1× 40 0.2× 313 1.6× 31 0.2× 21 1.7k
Tetsuo Nishiura Japan 22 640 1.0× 117 0.4× 134 0.6× 81 0.4× 138 0.9× 44 1.2k
Joyce Chan United States 14 730 1.1× 25 0.1× 152 0.7× 108 0.6× 63 0.4× 21 1.5k
Linda M.S. Fritze United States 16 840 1.3× 198 0.7× 61 0.3× 163 0.9× 52 0.3× 20 1.7k
Robert J. Fram United States 25 903 1.4× 101 0.3× 106 0.5× 77 0.4× 106 0.7× 82 1.6k
Roberta Bonfanti Italy 11 477 0.7× 28 0.1× 81 0.4× 165 0.9× 108 0.7× 17 1.8k

Countries citing papers authored by Mark Hansen

Since Specialization
Citations

This map shows the geographic impact of Mark Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hansen more than expected).

Fields of papers citing papers by Mark Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hansen. The network helps show where Mark Hansen may publish in the future.

Co-authorship network of co-authors of Mark Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hansen. A scholar is included among the top collaborators of Mark Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hansen. Mark Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnes, Bret, Anita Pottekat, Elisa Majounie, et al.. (2025). Scalable screening of ternary-code DNA methylation dynamics associated with human traits. Cell Genomics. 5(9). 100929–100929. 1 indexed citations
2.
Xie, Min, Myo Minn Oo, Mark Hansen, et al.. (2023). Wild mouse gut microbiota limits initial tuberculosis infection in BALB/c mice. PLoS ONE. 18(7). e0288290–e0288290. 1 indexed citations
3.
Hansen, Mark, Firat Kaya, Bernard Siow, et al.. (2023). A preclinical model of TB meningitis to determine drug penetration and activity at the sites of disease. Antimicrobial Agents and Chemotherapy. 67(12). e0067123–e0067123. 2 indexed citations
4.
Arnold, John J., Mark Hansen, Gregory S. Gorman, et al.. (2013). The Effect of Rho-Associated Kinase Inhibition on the Ocular Penetration of Timolol Maleate. Investigative Ophthalmology & Visual Science. 54(2). 1118–1118. 24 indexed citations
5.
Mathew, Sam J., Allyson J. Merrell, Malea M. Murphy, et al.. (2010). Connective tissue fibroblasts and Tcf4 regulate myogenesis. Development. 138(2). 371–384. 247 indexed citations
6.
Taniguchi, Eri, Min Jung Cho, Benjamin R. Arenkiel, et al.. (2009). Bortezomib reverses a post‐translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. Pediatric Blood & Cancer. 53(2). 136–144. 26 indexed citations
7.
Nishijo, Koichi, Tohru Hosoyama, Christopher R.R. Bjornson, et al.. (2009). Biomarker system for studying muscle, stem cells, and cancer in vivo. The FASEB Journal. 23(8). 2681–2690. 114 indexed citations
9.
Rösner, Assami, Bart Bijnens, Mark Hansen, et al.. (2008). Left ventricular size determines tissue Doppler-derived longitudinal strain and strain rate. European Journal of Echocardiography. 10(2). 271–277. 88 indexed citations
10.
Hatjiharissi, Evdoxia, Mark Hansen, Daniel Santos, et al.. (2007). Genetic Linkage of FcγRIIa and FcγRIIIa and Implications for Their Use in Predicting Clinical Responses to CD20-Directed Monoclonal Antibody Therapy. 1(1). 74–78. 1 indexed citations
11.
Schienda, Jaclyn, Kurt A. Engleka, Susan J. Jun, et al.. (2006). Somitic origin of limb muscle satellite and side population cells. Proceedings of the National Academy of Sciences. 103(4). 945–950. 157 indexed citations
12.
Treon, Steven P., Mark Hansen, Andrew R. Branagan, et al.. (2005). Polymorphisms in FcγRIIIA (CD16) Receptor Expression Are Associated With Clinical Response to Rituximab in Waldenström’s Macroglobulinemia. Journal of Clinical Oncology. 23(3). 474–481. 185 indexed citations
13.
Stanton, Eric, Mark Hansen, Harindra C. Wijeysundera, et al.. (2004). A Direct Comparison of the Natriuretic Peptides and Their Relationship to Survival in Chronic Heart Failure of a Presumed Non-Ischaemic Origin. European Journal of Heart Failure. 7(4). 557–565. 27 indexed citations
14.
Wijeysundera, Harindra C., Mark Hansen, Eric Stanton, et al.. (2003). Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. American Heart Journal. 146(2). 291–297. 25 indexed citations
15.
Rowley, David, Mark Hansen, Denise Rhodes, et al.. (2002). Thalassiolins A–C: new marine-derived inhibitors of HIV cDNA integrase. Bioorganic & Medicinal Chemistry. 10(11). 3619–3625. 101 indexed citations
16.
Molteni, Valentina, Denise Rhodes, Kathleen Rubins, et al.. (2000). A New Class of HIV-1 Integrase Inhibitors:  The 3,3,3‘,3‘-Tetramethyl-1,1‘-spirobi(indan)-5,5‘,6,6‘-tetrol Family. Journal of Medicinal Chemistry. 43(10). 2031–2039. 52 indexed citations
17.
Reddy, M. Venkata Rami, M. Rama Rao, Denise Rhodes, et al.. (1999). Lamellarin α 20-Sulfate, an Inhibitor of HIV-1 Integrase Active against HIV-1 Virus in Cell Culture. Journal of Medicinal Chemistry. 42(11). 1901–1907. 257 indexed citations
18.
Hansen, Mark, et al.. (1998). Retroviral cDNA Integration: Mechanism, Applications and Inhibition. PubMed. 20. 41–61. 33 indexed citations
19.
Wortsman, Jacobo, et al.. (1982). Incomplete differentiation of Wolffian structures: a form of Kallmann’s syndrome?. Fertility and Sterility. 37(1). 123–125. 4 indexed citations
20.
Hansen, Mark, et al.. (1978). [Cytostatic treatment of apudomas].. PubMed. 140(18). 1022–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026